TAR
ABBV icon

Trask Adam Roland’s AbbVie ABBV Stock Holding History

Trask Adam Roland’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.83M Buy
+13,003
New +$2.88M 2.68% 11

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Trask Adam Roland's ABBV Position: Q1 2026 in Review

Trask Adam Roland opened a new position in AbbVie (ABBV) in Q1 2026: 13,003 shares worth $2.83M. The stake represents 2.68% of the portfolio and ranks #11 among its holdings.

4,096 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Trask Adam Roland held 13,003 shares of AbbVie worth $2.83M as of Q1 2026.
  • AbbVie was a new Trask Adam Roland position in Q1 2026.
  • AbbVie made up 2.68% of Trask Adam Roland's portfolio in Q1 2026, its #11 holding.
  • 4,096 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Trask Adam Roland's 13F filing for Q1 2026, filed 15 May 2026.